GTC
Ghost Tree Capital’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $12.1M | Sell |
135,000
-15,000
| -10% | -$1.35M | 3.66% | 4 |
|
|
2024
Q2 | $12.1M | Sell |
150,000
-60,000
| -29% | -$4.83M | 3.78% | 4 |
|
|
2024
Q1 | $16.8M | Buy |
210,000
+45,000
| +27% | +$3.59M | 4.64% | 1 |
|
|
2023
Q4 | $13.1M | Buy |
165,000
+55,000
| +50% | +$4.38M | 4.29% | 1 |
|
|
2023
Q3 | $7.69M | Hold |
110,000
| – | – | 2.53% | 6 |
|
|
2023
Q2 | $7.9M | Sell |
110,000
-115,000
| -51% | -$8.26M | 2.61% | 13 |
|
|
2023
Q1 | $13.9M | Sell |
225,000
-10,000
| -4% | -$617K | 4.1% | 3 |
|
|
2022
Q4 | $18.1M | Sell |
235,000
-65,000
| -22% | -$5.01M | 7.74% | 2 |
|
|
2022
Q3 | $13.4M | Buy |
300,000
+75,000
| +33% | +$3.35M | 3.76% | 5 |
|
|
2022
Q2 | $8.62M | Buy |
225,000
+130,500
| +138% | +$5M | 4.49% | 4 |
|
|
2022
Q1 | $3.91M | Buy |
+94,500
| New | +$3.91M | 0.85% | 18 |
|
|
2020
Q3 | – | Sell |
-100,000
| Closed | -$8.23M | – | 47 |
|
|
2020
Q2 | $8.23M | Sell |
100,000
-115,000
| -53% | -$9.46M | 2.17% | 16 |
|
|
2020
Q1 | $12.6M | Buy |
215,000
+15,000
| +8% | +$882K | 3.35% | 5 |
|
|
2019
Q4 | $20.7M | Sell |
200,000
-475,000
| -70% | -$49.1M | 3.94% | 3 |
|
|
2019
Q3 | $13.7M | Sell |
675,000
-175,000
| -21% | -$3.54M | 3.48% | 8 |
|
|
2019
Q2 | $21.9M | Buy |
850,000
+540,000
| +174% | +$13.9M | 4.54% | 5 |
|
|
2019
Q1 | $4.41M | Buy |
+310,000
| New | +$4.41M | 1.15% | 29 |
|